UBC Faculty of Medicine researchers are part of a new national network that recently received $20 million in federal funding from the Canadian Institutes of Health Research Rare Disease Research Initiative for… Read More
Data show how AbCellera is expanding the reach of T-cell engagers with: CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor… Read More
RESEARCH TRIANGLE PARK, NC and SAN FRANCISCO, CA – IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the… Read More
LAVAL, QC – Bausch Health Companies Inc. (NYSE/TSX: BHC) along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced that it filed a lawsuit in the United States District Court for… Read More
More than one billion people worldwide live with migraine,[i] and the World Health Organization classifies migraine as the second leading cause of disability in the world.[ii] KIRKLAND, QC – NURTEC ODT®… Read More
